Walleye Capital
TAK icon

Walleye Capital’s Takeda Pharmaceutical TAK Stock Holding History

Walleye Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$609K Buy
38,000
+33,600
+764% +$556K ﹤0.01% 2545
2026
Q1 		$81.5K Buy
+4,400
New +$77.2K ﹤0.01% 3746

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Walleye Capital's TAK Position: Q2 2026 in Review

Walleye Capital reduced its Takeda Pharmaceutical (TAK) stake by 94% in Q2 2026, selling an estimated $4.06M and leaving 15,469 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #3330.

Walleye Capital first reported a position in TAK in Q3 2023 and has held it in 7 quarters since. The position peaked at $4.83M in Q1 2026. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Walleye Capital held 15,469 shares of Takeda Pharmaceutical worth $248K as of Q2 2026.
  • Walleye Capital sold 245,348 Takeda Pharmaceutical shares in Q2 2026, an estimated $4.06M.
  • Takeda Pharmaceutical made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3330 holding.
  • Walleye Capital first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 7 quarters since.
  • Walleye Capital's Takeda Pharmaceutical position peaked at $4.83M in Q1 2026.
  • 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.